| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2567684 | Pulmonary Pharmacology & Therapeutics | 2007 | 9 Pages |
Abstract
Once-daily ciclesonide was more effective than once-daily budesonide in improving FEV1, FVC and PEF. Ciclesonide also had an earlier onset of action than budesonide in patients with persistent asthma. Both ciclesonide and budesonide had good safety and tolerability profiles.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Dieter Ukena, Christian Biberger, Volker Steinijans, Volker von Behren, Ronitta Malek, Hans H. Weber, Ekkehard Beck, Anneliese Linnhoff,